Contract 75A50120C00092

Phlow Corp. · Department Of Health And Human Services · September 26, 2023

Cost Plus Fixed FeeSole SourceNAICS 325412

Phlow Corp. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 26, 2023 for $255.41 million of work in pharmaceutical preparation manufacturing. Performance is in Richmond, VA. It was awarded under full and open competition. The contract has been modified 19 times since the base award It uses cost-plus contract pricing. The most recent modification was on March 3, 2026. If all options are exercised, the contract could reach $969.75 million.

Obligated to date
$255.41M
$255,409,954
Current value
$708.85M
Potential value
$969.75M
if all options exercised
Modifications
19
Latest March 3, 2026

Contract details

PIID
75A50120C00092
Award type
Definitive Contract
Pricing
Cost Plus Fixed Fee
Set-aside
No Set Aside Used.
Competition
Not Competed
NAICS
325412 · Pharmaceutical Preparation Manufacturing
Product / service
R&D- Medical: Biomedical (Commercialized)
Place of performance
Richmond, VA
First action
September 26, 2023
Latest action
March 3, 2026

Description

THE PURPOSE OF THIS ACTION IS TO UPDATE THE PLANNED DEFINITIZATION DATE IN P0022 FROM MARCH 3, 2026 TO MAY 3, 2026

Modification timeline

  • March 3, 2026
    Mod P00030 · Definitize Change Order
    $696.67M
  • February 19, 2026
    Mod P00029 · Definitize Change Order
    THE PURPOSE OF THIS ACTION IS TO UPDATE THE PLANNED DEFINITIZATION DATE IN P0025 FROM FEB 25, 2026 TO APRIL 25, 2026
    $696.67M
  • January 30, 2026
    Mod P00028 · Supplemental Agreement For Work Within Scope
    THE PURPOSE OF THIS ACTION IS TO EXTEND CLIN 0008 AT NO ADDITIONAL COST TO THE GOVERNMENT
    $696.67M
  • January 26, 2026
    Mod P00026 · Change Order
    THE PURPOSE OF THIS ACTION IS TO FUND THE REMAINING APIS FOR THE STRATEGIC RESERVE
    $696.67M
  • January 26, 2026
    Mod P00027 · Exercise An Option
    THE PURPOSE OF THIS ACTION IS TO FUND THE REMAINING APIS FOR THE STRATEGIC RESERVE
    $696.67M
  • January 5, 2026
    Mod P00025 · Other Administrative Action
    THE PURPOSE OF MODIFICATION P00020 IS TO EXERCISE OPTION CLIN 0010 AND INCORPORATE CHANGES TO THE DESCRIPTION OF SERVICES FOR DOMESTIC PRODUCIBILITY OF ESSENTIAL MEDICINES.
    $616.39M
  • December 12, 2025
    Mod P00024 · Other Administrative Action
    COR CHANGE
    $616.39M
  • December 1, 2025
    Mod P00023 · Supplemental Agreement For Work Within Scope
    ADD CLAUSE FAR 52.232-16 PROGRESS PAYMENTS (NOV 2021) ALTERNATE I (MAR 2000)
    $616.39M
  • November 4, 2025
    Mod P00022 · Change Order
    REVISE THE SCOPE OF EFFORT
    $616.39M
  • October 23, 2025
    Mod P00021 · Other Administrative Action
    UPDATE POC INFORMATION
    $591.39M

Similar contracts

RecipientAgencyDateObligated
Astrazeneca Pharmaceuticals LpDepartment Of Health And Human ServicesMarch 31, 2026$122.8K
Four Points Technology, L.L.C.Department Of Health And Human ServicesMarch 31, 2026$246.6K
Mckesson CorporationDepartment Of Health And Human ServicesMarch 30, 2026$9.00M
Emergent Biosolutions Canada IncDepartment Of Health And Human ServicesMarch 30, 2026$256.40M
Ase Direct, Inc.Department Of Health And Human ServicesMarch 30, 2026$49.0K
Merck Sharp & Dohme LlcDepartment Of Health And Human ServicesMarch 27, 2026$361.34M

Top contractors in NAICS 325412

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Mckesson Corporation1,187$4.96B
2Merck Sharp & Dohme Llc26$894.71M
3Sanofi Vaccines Us Inc.57$702.38M
4Pfizer Inc169$541.15M
5Glaxosmithkline, Llc14$505.04M
6Phlow Corp.1$105.27M
7Exelan Pharmaceuticals Inc76$104.30M
8Seqirus USA Inc47$59.15M
9Emergent Biosolutions Canada Inc2$53.73M
10Mckesson Specialty Distribution Llc1$51.05M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75A50120C00092?

Contract 75A50120C00092 is a federal contract awarded to Phlow Corp. by Department Of Health And Human Services on September 26, 2023 for $255.41 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 19 times since the base award.

Who won contract 75A50120C00092?

Phlow Corp. won contract 75A50120C00092 from Department Of Health And Human Services.

How much is contract 75A50120C00092 worth?

Contract 75A50120C00092 has obligated $255.41 million to date, with a total potential value of $969.75 million if all options are exercised.